Employed somebody new and thrilling? Promoted a rising star? Lastly solved that hard-to-fill spot? Share the information with us, and we’ll share it with others. That’s proper. Ship us your modifications, and we’ll discover a house for them. Don’t be shy. Everybody desires to know who’s coming and going.
And right here is our common function through which we spotlight a distinct particular person every week. This time round, we be aware that Syndax Prescription drugs employed Nicholas Botwood as head of analysis and improvement and chief medical officer. Beforehand, he labored at Bristol Myers Squibb, the place he was senior vice chairman, head of worldwide medical oncology.
However all work and no play could make for a uninteresting chief medical officer and R&D head.
